Category: Policy

Mourning The Many Foibles Of Medicare And Medicaid At 55

Today, Medicare and Medicaid mark their 55th birthdays, a day that should remind us of the damage that ill-conceived healthcare reforms can inflict. Little did President Lyndon Johnson know when he signed the programs into law that he’d be setting the …

Cutting Drug Prices? What You Need To Know

The move to slap price controls on prescription drugs will be a disaster, wrecking our cutting-edge pharmaceutical companies and foisting a sicker future on us.

India’s Covid-19 Fallout Collides With A Shaky Economy

The second-most populous nation has its work cut out to deal with a surge in domestic infections and global turmoil.

How Infectious Diseases Like Covid-19 Get Their Names—And Why It’s Important To Use Them Correctly

Infectious disease expert Dr. Dave Wessner explains how infectious diseases get their names, and why using those names properly is an important aspect of fighting them.

Is now the time for single payer?

With the news that nearly $6 million Americans have lost their employer-sponsored health due to COVID, it is finally time to ask ourselves: is the “American Model” of health care working? The “American Model” is a system of fragmentation: one in which …

Facebook Takes Down Viral Video Making False Claim That ‘Hydroxychloroquine Cures Covid’

Facebook, YouTube and Twitter have deleted a viral video titled “America’s Frontline Doctors” that attracted millions of views with dubious claims about hydroxychloroquine.

Birx Visits Tennessee, Pushes For Mandatory Masks

91% of the state’s counties are above the threshold for acceptable virus transmission level.

Spain’s Coronavirus Cases Rise To Worrying Levels After Weeks Of Staying Low

Other European nations, such as Germany and France, are also seeing their numbers rise after lifting some of their toughest restrictions.

Spain’s Coronavirus Cases Rise To Worrying Levels After Weeks Of Staying Low

Other European nations, such as Germany and France, are also seeing their numbers rise after lifting some of their toughest restrictions.

Driving culture change in the pursuit of oncology value

Five years ago, if you asked oncologists at my practice to name the list price of a given chemotherapy agent, most wouldn’t have known–unless they were executives, maybe. Pharmaceutical reps rarely talk about costs. The EMRs don’t give list price…